Company / Operating Cash Flow per Share
Vistagen Therapeutics, Inc. Operating Cash Flow per Share History
FY2011-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.37
FY2021
5-year range
-$3.08 / -$0.37
FY2017-FY2021
Trend
+74.0%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 6 years, ranging from $-3.08 in FY2017 to $-0.16 in FY2011.
Based on SEC 10-K filings.
-0.37 in FY2021.
Improved from $-3.08 to $-0.37 over the past 4 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, operating cash flow per share increased 74.0% year-over-year.
- Peak operating cash flow per share was recorded in FY2011.
- Lowest operating cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -$0.37 | +74.0% |
| FY2018 | -$1.42 | +53.8% |
| FY2017 | -$3.08 | -1512.3% |
| FY2014 | -$0.19 | +40.4% |
| FY2012 | -$0.32 | -100.0% |
| FY2011 | -$0.16 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026